logo biblio digital exactas
logo twitter logo instagram logo whatsapp logo mail

Navegar

Colección

Datos Estadísticas

Lista de

prolactinoma
43
"Sex differences in the pituitary transforming growth factor-β1 system: Studies in a model of resistant prolactinomas" (2013) Recouvreux, M.V.;Lapyckyj, L.;Camilletti, M.A. (...)Díaz-Torga, G. Endocrinology. 154(11):4192-4205
"Sex differences in the pituitary transforming growth factor-β1 system: Studies in a model of resistant prolactinomas" (2013) Recouvreux, M.V.;Lapyckyj, L.;Camilletti, M.A. (...)Díaz-Torga, G. Endocrinology. 154(11):4192-4205
"Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1)" (2012) Recouvreux, M.V.;Camilletti, M.A.;Rifkin, D.B. (...)Díaz-Torga, G. Endocrinology. 153(8):3861-3871
"Thrombospondin-1 (TSP-1) analogs ABT-510 and ABT-898 inhibit prolactinoma growth and recover active pituitary transforming growth factor-β1 (TGF-β1)" (2012) Recouvreux, M.V.;Camilletti, M.A.;Rifkin, D.B. (...)Díaz-Torga, G. Endocrinology. 153(8):3861-3871
"Cellular and molecular specificity of pituitary gland physiology" (2012) Perez-Castro, C.;Renner, U.;Haedo, M.R. (...)Arzt, E. Physiological Reviews. 92(1):1-38
"Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas" (2011) Luque, G.M.;Perez-Millán, M.I.;Ornstein, A.M. (...)Becu-Villalobos, D. Journal of Pharmacology and Experimental Therapeutics. 337(3):766-774
"Inhibitory effects of antivascular endothelial growth factor strategies in experimental dopamine-resistant prolactinomas" (2011) Luque, G.M.;Perez-Millán, M.I.;Ornstein, A.M. (...)Becu-Villalobos, D. Journal of Pharmacology and Experimental Therapeutics. 337(3):766-774
"Pituitary tumors: Cell type-specific roles for BMP-4" (2010) Labeur, M.;Páez-Pereda, M.;Haedo, M. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 326(1-2):85-88
"Pituitary tumors: Cell type-specific roles for BMP-4" (2010) Labeur, M.;Páez-Pereda, M.;Haedo, M. (...)Stalla, G.K. Molecular and Cellular Endocrinology. 326(1-2):85-88
"Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels" (2010) Ahtiainen, P.;Sharp, V.;Rulli, S.B. (...)Huhtaniemi, I. Endocrine-Related Cancer. 17(3):611-621
"Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels" (2010) Ahtiainen, P.;Sharp, V.;Rulli, S.B. (...)Huhtaniemi, I. Endocrine-Related Cancer. 17(3):611-621
"Enhanced LH action in transgenic female mice expressing hCGβ-subunit induces pituitary prolactinomas; the role of high progesterone levels" (2010) Ahtiainen, P.;Sharp, V.;Rulli, S.B. (...)Huhtaniemi, I. Endocrine-Related Cancer. 17(3):611-621
"New insights into the endocrine and metabolic roles of dopamine D2 receptors gained from the Drd2-/- mouse" (2010) Garcia-Tornadú, I.;Perez-Millan, M.I.;Recouvreux, V. (...)Becu-Villalobos, D. Neuroendocrinology. 92(4):207-214
"Novel medical therapies for pituitary tumors" (2010) Theodoropoulou, M.;Labeur, M.;Paez Pereda, M. (...)Stalla, G.K. Frontiers of Hormone Research. 38:158-164
"VEGF and CD31 association in pituitary adenomas" (2010) Cristina, C.;Perez-Millan, M.I.;Luque, G. (...)Becu-Villalobos, D. Endocrine Pathology. 21(3):154-160
"Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: An international collaborative study" (2010) Daly, A.F.;Tichomirowa, M.A.;Petrossians, P. (...)Beckers, A. Journal of Clinical Endocrinology and Metabolism. 95(11):E373-E383
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"Invasive giant prolactinoma with loss of therapeutic response to cabergoline: Expression of angiogenic markers" (2009) Mallea-Gil, M.S.;Cristina, C.;Perez-Millan, M.I. (...)Becu-Villalobos, D. Endocrine Pathology. 20(1):35-40
"Differential gene expression in models of pituitary prolactin-producing tumoral cells" (2009) Giacomini, D.;Haedo, M.;Gerez, J. (...)Arzt, E. Hormone Research. 71(SUPPL2):88-94
"Differential gene expression in models of pituitary prolactin-producing tumoral cells" (2009) Giacomini, D.;Haedo, M.;Gerez, J. (...)Arzt, E. Hormone Research. 71(SUPPL2):88-94
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes" (2007) Cristina, C.;Díaz-Torga, G.S.;Goya, R.G. (...)Becu-Villalobos, D. Molecular Cancer. 6
"Phenotypic characterisation of mice with exaggerated and missing LH/hCG action" (2007) Ahtiainen, P.;Rulli, S.;Pakarainen, T. (...)Huhtaniemi, I. Molecular and Cellular Endocrinology. 260-262:255-263
"Pituitary action of cytokines: Focus on BMP-4 and gp130 family" (2007) Giacomini, D.;Acuña, M.;Gerez, J. (...)Arzt, E. Neuroendocrinology. 85(2):94-100
"Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice" (2007) Cristina, C.;Díaz-Torga, G.;Góngora, A. (...)Becu-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 293(5):E1341-E1351
"Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice" (2007) Cristina, C.;Díaz-Torga, G.;Góngora, A. (...)Becu-Villalobos, D. American Journal of Physiology - Endocrinology and Metabolism. 293(5):E1341-E1351
"Dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma" (2006) Cristina, C.;García-Tornadú, I.;Díaz-Torga, G. (...)Bronstein M. Frontiers of Hormone Research. 35:50-63
"Dopaminergic D2 receptor knockout mouse: An animal model of prolactinoma" (2006) Cristina, C.;García-Tornadú, I.;Díaz-Torga, G. (...)Bronstein M. Frontiers of Hormone Research. 35:50-63
"Molecular understanding of cytokine-steroid hormone dialogue: Implications for human diseases" (2006) Druker, J.;Liberman, A.C.;Acuña, M. (...)Arzt, E. Annals of the New York Academy of Sciences. 1088:297-306
"Multiple sites of tumorigenesis in transgenic mice overproducing hCG" (2005) Huhtaniemi, I.; Rulli, S.; Ahtiainen, P.; Poutanen, M. Molecular and Cellular Endocrinology. 234(1-2):117-126
"Multiple sites of tumorigenesis in transgenic mice overproducing hCG" (2005) Huhtaniemi, I.; Rulli, S.; Ahtiainen, P.; Poutanen, M. Molecular and Cellular Endocrinology. 234(1-2):117-126
"Signaling processes in tumoral neuroendocrine pituitary cells as potential targets for therapeutic drugs" (2005) Paez-Pereda, M.;Giacomini, D.;Echenique, C. (...)Arzt, E. Current Drug Targets: Immune, Endocrine and Metabolic Disorders. 5(3):259-267
"Estradiol Stimulates Vascular Endothelial Growth Factor and Interleukin-6 in Human Lactotroph and Lactosomatotroph Pituitary Adenomas" (2004) Onofri, C.;Carbia Nagashima, A.;Schaaf, L. (...)Arzt, E. Experimental and Clinical Endocrinology and Diabetes. 112(1):18-23
"Integrating systemic information at the molecular level: Cross-talk between steroid receptors and cytokine signaling on different target cells" (2003) Refojo, D.;Liberman, A.C.;Giacomini, D. (...)Arzt, E. Annals of the New York Academy of Sciences. 992:196-204
"Integrating systemic information at the molecular level: Cross-talk between steroid receptors and cytokine signaling on different target cells" (2003) Refojo, D.;Liberman, A.C.;Giacomini, D. (...)Arzt, E. Annals of the New York Academy of Sciences. 992:196-204
"New mechanisms involved in the pathogenesis of pituitary adenomas " (2003) Giacomini, D.;Paez-Pereda, M.;Refojo, D. (...)Arzt, E. Medicina. 63(2):147-150
"New mechanisms involved in the pathogenesis of pituitary adenomas " (2003) Giacomini, D.;Paez-Pereda, M.;Refojo, D. (...)Arzt, E. Medicina. 63(2):147-150
"Laminin inhibits lactotroph proliferation and is reduced in early prolactinoma development" (2003) Kuchenbauer, F.;Theodoropoulou, M.;Hopfner, U. (...)Páez-Pereda, M. Molecular and Cellular Endocrinology. 207(1-2):13-20
"Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk" (2003) Páez-Pereda, M.;Giacomini, D.;Refojo, D. (...)Arzt, E. Proceedings of the National Academy of Sciences of the United States of America. 100(3):1034-1039
"Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk" (2003) Páez-Pereda, M.;Giacomini, D.;Refojo, D. (...)Arzt, E. Proceedings of the National Academy of Sciences of the United States of America. 100(3):1034-1039